Mark Stanley Berger - 27 Feb 2026 Form 4 Insider Report for Genprex, Inc. (GNPX)

Role: Chief Medical Officer
Signature: /s/ Mark Berger
Issuer symbol: GNPX
Transactions as of: 27 Feb 2026
Net transactions value: -$14,336
Form type: 4
Filing time: 27 Feb 2026, 18:34:18 UTC
Previous filing: 23 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Berger Mark Stanley	Chief Medical Officer	3300 BEE CAVE ROAD, #650-227, AUSTIN	/s/ Mark Berger	27 Feb 2026	0001700283

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GNPX	Common Stock	Tax liability	$14,336	-7,168	-25%	$2.00	21,692	27 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025).